DNLI

DNLI Net Income Growth

-6.77%TTM

Period ending:

DNLI TTM Net Income YoY %%
DNLI TTM Net Income YoY %287.13%-1274.55%
2017-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

DNLI net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 35 observations from Dec 31, 2017 to Jun 30, 2026.

Denali Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-6.7672%
-11.9126%
-21.2329%
-16.6672%
-14.1498%
-230.7523%
-191.1179%
-243.5638%
-226.897%
62.962%
55.4515%
58.8765%
54.7757%
-29.6725%
-12.1859%
-1,123.4196%
-607.578%
-593.8989%
-508.4866%
112.98%
125.9145%
126.8626%
135.9974%
-244.8195%
-291.1868%
-317.7852%
-445.2925%
51.664%
55.1972%
43.0613%
58.9046%
-61.4374%
-31.8072%
-1.0203%
-1.7691%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All DNLI financial metrics · DNLI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.